Cbdmd, INC 10-Q quarterly reports

cbdMD, Inc. reported a 12% decline in Q3 net sales but significantly improved stockholders' equity and NYSE American listing compliance through a preferred stock conversion and reverse stock split.

cbdMD, Inc. reports its Q2 2025 financial results, highlighting a focus on profitability, strategic initiatives, and addressing compliance with NYSE American continued listing standards.

cbdMD, Inc. reports its first quarter fiscal 2025 results, highlighting net income achievement and positive EBITDA, marking a turning point in the company's financial performance.

cbdMD, Inc. reported its Q3 2024 financial results, highlighting a focus on cost reduction and revenue growth initiatives despite a year-over-year decrease in net sales.

cbdMD, Inc. reported a net loss for the second quarter of 2024, while implementing cost-cutting measures and strategic shifts to improve profitability.

cbdMD, Inc. reported a decrease in net sales for the first quarter of fiscal year 2024, alongside a reduction in operating expenses as the company focuses on profitability and strategic initiatives.